ro6870810
Showing 1 - 5 of 5
Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma Trial in Worldwide (RO6870810, Venetoclax, Rituximab)
Completed
- Diffuse Large B-cell Lymphoma
- High-Grade B-cell Lymphoma
- RO6870810
- +2 more
-
Duarte, California
- +8 more
Jan 21, 2022
Advanced Ovarian Cancer, Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab, RO6870810)
Terminated
- Advanced Ovarian Cancer
- Triple Negative Breast Cancer
- Atezolizumab
- RO6870810
-
Boston, Massachusetts
- +10 more
Nov 5, 2020
Multiple Myeloma Trial in Australia, United Kingdom, United States (RO6870810, daratumumab)
Completed
- Multiple Myeloma
- RO6870810
- daratumumab
-
Duarte, California
- +11 more
Feb 6, 2020
Solid Tumors, Advanced Solid Tumors Trial in United States (RO6870810)
Completed
- Solid Tumors, Advanced Solid Tumors
- RO6870810
-
New Haven, Connecticut
- +3 more
Jan 3, 2018
Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- RO6870810
-
Boston, Massachusetts
- +1 more
Dec 7, 2017